These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8867897)

  • 41. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.
    Feng Z; Gollamudi R; Dillingham EO; Bond SE; Lyman BA; Purcell WP; Hill RJ; Korfmacher WA
    J Med Chem; 1992 Aug; 35(16):2952-8. PubMed ID: 1501222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
    Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.
    Zheng X; Salgia SR; Thompson WB; Dillingham EO; Bond SE; Feng Z; Prasad KR; Gollamudi R
    J Med Chem; 1995 Jan; 38(1):180-8. PubMed ID: 7837229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.
    Perera L; Darden TA; Pedersen LG
    Biophys J; 1999 Jul; 77(1):99-113. PubMed ID: 10388743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
    Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
    Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
    Szalony JA; Suleymanov OD; Salyers AK; Panzer-Knodle SG; Blom JD; LaChance RM; Case BL; Parlow JJ; South MS; Wood RS; Nicholson NS
    Thromb Res; 2003; 112(3):167-74. PubMed ID: 14967414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status on tissue factor activation of factor VIIa.
    Persson E; Olsen OH
    Thromb Res; 2010 Apr; 125 Suppl 1():S11-2. PubMed ID: 20153879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand.
    Miura M; Seki N; Koike T; Ishihara T; Niimi T; Hirayama F; Shigenaga T; Sakai-Moritani Y; Kawasaki T; Sakamoto S; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2006 Dec; 14(23):7688-705. PubMed ID: 16942884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of different human and animal thromboplastins with human factor VIIa in the presence of aprotinin.
    Chabbat J; Porte P; Tellier M; Steinbuch M
    Thromb Res; 1995 Feb; 77(4):387-92. PubMed ID: 7537922
    [No Abstract]   [Full Text] [Related]  

  • 53. Factor Xa generation at the surface of cultured rat vascular smooth muscle cells in an in vitro flow system.
    Hall CL; Taubman MB; Nemerson Y; Turitto VT
    J Biomech Eng; 1998 Aug; 120(4):484-90. PubMed ID: 10412419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of different human and animal thromboplastins with human factor VIIa in the presence of aprotinin.
    Chabbat J; Porte P; Tellier M; Steinbuch M
    Thromb Res; 1994 Jul; 75(2):213-8. PubMed ID: 7526485
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chiral resolution of alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene, a novel antiplatelet compound.
    Gollamudi R; Feng ZX
    Chirality; 1991; 3(6):480-3. PubMed ID: 1812959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS; Dickinson CD; Ruf W
    Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.
    Gir S; Reavis R; Turitto VT; Gollamudi R
    Biotechnol Appl Biochem; 1996 Feb; 23(1):63-6. PubMed ID: 8867897
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.